Up to now, the three most frequent alterations that have been reported in ACC patients include overexpression of IGF2 (93, 94), activation of WNT/β-catenin signaling pathway (11, 77, 95), and inactivation of TP53/RB pathway (96, 97). Here, RB1 is linked to adrenal cortex carcinoma.